References

Fields WS, Lemak NA, Frankowski RF, Hardy RJ.
Controlled trial of aspirin in cerebral ischemia.
Stroke 1977 May-Jun;8(3):301-14.
Stroke Trials Directory entry: AITIA

Fields WS, Lemak NA, Frankowski RF, Hardy RJ.
Controlled trial of aspirin in cerebral ischemia. Part II: surgical group.
Stroke 1978 Jul-Aug;9(4):309-19.

Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, Touboul PJ.
"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
Stroke 1983 Jan-Feb;14(1):5-14.
Stroke Trials Directory entry: AICLA

Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, Touboul PJ.
The A.I.C.L.A. controlled cooperative trial. Secondary prevention of cerebral ischemic accidents due to atherosclerosis by aspirin and dipyridamole. 3: Results.
Rev Neurol (Paris) 1983;139(5):335-48.

Sorensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, Munck O, Andersen LA.
Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.
Stroke 1983 Jan-Feb;14(1):15-22.
Stroke Trials Directory entry: Danish Cooperative Study

High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study.
Stroke 1987 Mar-Apr;18(2):325-34.
Stroke Trials Directory entry: Swedish Cooperative Study

Boysen G, Sorensen PS, Juhler M, Andersen AR, Boas J, Olsen JS, Joensen P.
Danish very-low-dose aspirin after carotid endarterectomy trial.
Stroke. 1988 Oct;19(10):1211-5.
Stroke Trials Directory entry: Danish very-low-dose aspirin . . .

Farrell B, Godwin J, Richards S, Warlow C.
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
J Neurol Neurosurg Psychiatry 1991 Dec;54(12):1044-54.
Stroke Trials Directory entry: UK-TIA

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group.
Lancet. 1991 Nov 30;338(8779):1345-9.

Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A.
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
J Neurol Sci. 1996 Nov;143(1-2):1-13.
Stroke Trials Directory entry: ESPS-2

Taylor DW, Barnett HJ, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, Simard D, Silver FL, Hachinski V, Clagett GP, Barnes R, Spence JD.
Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators.
Lancet. 1999 Jun 26;353(9171):2179-84.
Stroke Trials Directory entry: ACE

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke.
The Dutch TIA Trial Study Group.
N Engl J Med. 1991 Oct 31;325(18):1261-6.
Stroke Trials Directory entry: Dutch TIA

Food & Drug Administration. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products. Federal Register. 1998; 63: 56802–56819.

Schafer AI.
Antiplatelet therapy.
Am J Med. 1996 Aug;101(2):199-209.

WK Hass, JD Easton, HP Adams, W Pryse-Phillips, BA Molony, S Anderson, and B Kamm
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group
N Engl J Med. 1989 Aug 24;321(8):501-7.
Stroke Trials Directory entry: TASS

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
Lancet 1996 Nov 16;348(9038):1329-1339
Stroke Trials Directory entry: CAPRIE

European Stroke Prevention Study. ESPS Group.
Stroke. 1990 Aug;21(8):1122-30.

The American-Canadian Co-Operative Study group.
Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results.
Stroke. 1985 May-Jun;16(3):406-15.
Stroke Trials Directory entry: Persantine Aspirin Trial

Guiraud-Chaumeil B, Rascol A, David J, Boneu B, Clanet M, Bierme R.
Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial.
Rev Neurol (Paris). 1982;138(5):367-85.

European Stroke Prevention Study 2. Efficacy and safety data.
J Neurol Sci. 1997 Sep;151 Suppl:S1-77.

Dresse A, Chevolet C, Delapierre D, Masset H, Weisenberger H, Bozler G, Heinzel G.
Pharmacokinetics of oral dipyridamole (Persantine) and its effect on platelet adenosine uptake in man.
Eur J Clin Pharmacol. 1982;23(3):229-34.

Diener HC.
Dipyridamole trials in stroke prevention.
Neurology. 1998 Sep;51(3 Suppl 3):S17-9.

Antithrombotic Trialists' Collaboration.
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
BMJ. 2002 Jan 12;324(7329):71-86.

Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators.
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.
Lancet. 2004 Jul 24;364(9431):331-7.
Stroke Trials Directory entry: MATCH